Cardiac cachexia;Caquexia cardíaca

Nutricion Hospitalaria

Volumn 21, Issue SUPPL. 3, 2006, Pages 84-93

  Miján, Alberto ^a,b   Martín, Elvira ^b   De Mateo, Beatriz ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Cachexia; Chronic heart failure; Cytokines; Inflammation; Muscle atrophy; Neurohormones; Nutrition

Indexed keywords

CACHEXIA; CALORIC INTAKE; DIET; ENERGY BALANCE; HEART FAILURE; HUMAN; INFLAMMATION; MALNUTRITION; METABOLIC DISORDER; NUTRITIONAL STATUS; OSTEOPOROSIS; REVIEW; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; PATHOPHYSIOLOGY;

CACHEXIA; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 33745114333     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Cowie MR, Mosterd A, Wood DA y cols.: The epidemiology of heart failure. Eur Heart J 1997; 18:208-225.
2. Mc Murray JJ, Stewart J: Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 833:596-602.
3. Goldberg RJ, Spencer FA, Farmer C y cols.: Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med 2005; 118:728-734.
4. Forman DE, Wei JY: Congestive heart failure in the elderly. En: Sheehan MN, Wei JY, editors. Geriatric Medicine: a case-based manual. New York: Oxford University Press; 1997. pp. 67-79.
5. Doehner W, Anker SD: Cardiac Cachexia in early literature: a review of research prior to Medline. Int J Cardiol 2002; 85:7-14.
6. Anker SD, Ponikowski P, Varney S y cols.: Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349:1050-1053.
7. Anker SD, Coats AJ. Cardiac Cachexia: a syndrome with impaired survival and inmune and neuroendocrine activation. Chest 1999; 115:836-847.
8. Anker SD, Negassa A, Coats AJ y cols.: Prognostic importance of weight lost in chronic heart failure and the effect with angiotensin-converting enzyme inhibitors: an observational study. Lancet 2003; 361:1077-1083.
9. Strassburg S, Springer J, Anker SD: Muscle wasting in cardiac cachexia. IJBCB 2005; 37:1938-1947.
10. Filippatos GS, Anker SD, Kremastinos DT: Pathophysiology of peripheral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care 2005; 8:249-254.
11. Anker SD, Steinborn W: Strassburg S. Cardiac cachexia. Ann Med 2004; 36:518-529.
12. Wei JY: Age and the cardiovascular system. N Engl J Med 1992; 327:1735-1739
13. Odiet JA, Wei JY: Heart failure and the aging myocardium. Heart Fail Rev 1996; 2:139-149.
14. KN Frayn: Metabolic Characteristics of the organs and tissues. En: Metabolic Regulation. A Human Perspective. Frontiers in Metabolism 1 (K Snell ed). Portland Press, London, 1996.
15. Florea VG, Henein MY, Rauchhaus M y cols.: The cardiac component of cardiac cachexia. Am Heart J 2002;144:45-50.
16. Pittmann JG, Cohen P: The pathogenesis of cardiac cachexia. N Engl J Med 1964; 271:403-409.
17. Heymsfield SB, Hoff RD, Gray TF y cols.: Heart Diseases. En: Nutrition and Metabolism in Patient Care. Kinney JM, Jeejeebhoy KN, Hill GL y Owen OE (ed); 1988. WB Saunders, Philadelphia; pp 477-509.
18. Miján de la Torre A, De Mateo Silleras B, Pérez García AMa: Nutrición y enfermedad cardíaca. En: Tratado de Nutrición, (A Gil ed.). Acción Médica, Madrid, 2005; vol IV:594-629.
19. Azhar G, Wei JY: Nutrition and cardiac cachexia. Curr Opin Clin Nutr Metab Care 2006; 9:18-23.
20. Pasini E, Opasich C, Pastoris O y cols.: Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure. Am J Cardiol 2004; 93 (Supl.):41A-43A.
21. Anker SD, Chua TP, Ponikowski P y cols.: Hormonal changes and catabolic / anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997; 96:526-534.
22. Rauchhaus M, Doehner W, Francis DP y cols.: Plasma cytokine parameters and mortality in patients with chronic heart failure, Circulation 2000; 102:3060-3067.
23. Anker SD, Clark AL, Kemp M y cols.: Tumor necrosis factor and steroid metabolism in chronic heart failure; possible relation to muscle wasting. J Am Coll Cardiol 1997; 30:997-1001.
24. Sharma R, Anker SD: Cytokines, apoptosis and cachexia: the potencial for TNF antagonism. Int J Cardiol 2002; 85:161-171.
25. Niebauer J, Pflaum CD, Clark AL y cols.: Deficient IGF-1 in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998; 32:393-397.
26. Anker SD, Volterrani M, Pflaum CD y cols.: Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 2001; 38:443-452.
27. Brink M, Wellen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating IGF-1 in rats through a pressor-independent mechanism. J Clin Invest 1996; 97:2509-2516.
28. Bolger AP, Sharma R, Li W y cols.: Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106:92-99.
29. Anker SD, Egerer KR, Volk HD y cols.: Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997; 79:1426-1430.
30. Niebauer J, Volk HD, Kemp M y cols.: Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353:1838-1842.
31. Torre-Amione G, Kapadia S, Lee J y cols.: Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93:704-711.
32. Bolger AP, Anker SD. TNF in chronic heart failure; a peripheral view of pahogenesis, clinical manifestations and therapeutic implications. Drugs 2000; 60:1245-1257.
33. Keith M, Geranmayegan A, Sole MJ y cols.: Increase oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998; 31:1352-1356
34. Keith ME, Jeejeebhoy KN, Langer A y cols.: A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001; 73:219-224.
35. Ferrari R, Bachetti T, Confortini R y cols.: Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart falilure. Circulation 1995; 92:1479-1486.
36. Krack A, Sharma R, Figulia HR y cols.: The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 2005. 26:2368-2374.
37. Vonhof S, Brost B, Stille-Siegener M y cols.: Monocyte activation in congestive heart failure due to coronary artery disease and idiophatic dilated cardiomyopathy. Int J Cardiol 1998; 63:237-244.
38. Oktedalen O, Lunde OC, Opstad PK y cols.: Changes in the gastrointestinal mucosa after long-distance running. Scand J Gastroenterol 1992; 27:270-274.
39. Brock-Utne JG, Gaffin SL, Wells MT y cols.: Endotoxemia in exhausted runners after a long-distance race. S Afr Med J 1988; 73:533-536.
40. Jeukendrup AE, Vet-Joop K, Sturk A y cols.: Relationship between GI complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long distance triathlon in highly trained men. Clin Sci (Lond) 2000; 98:47-55.
41. Rauchhaus M, Coats AJ, Anker SD: The endotoxin-lipoprotein hypothesis. Lancet 2000; 356:930-933.
42. Rauchhaus M, Clark AL, Doehner W y cols.: The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003; 42:1933-1940.
43. Kalantar-Zadeh K, Block G, Horwich T y cols.: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43:1439-1444.
44. Cabré E, Gassull MA: Evaluación de la función digestiva. En: Técnicas y Métodos de Investigación en Nutrición Humana (A Miján, ed) 2002. Glosa, Barcelona. pp. 231-249.
45. Schulze PC, Späte U: Insulin-like growth factor-1 and muscle wasting in chronic heart failure. Int J Biochem Cell Biol 2005; 37:2023-2035.
46. Song YH, Li Y, Du J: Anthropometric variables and physical activity as predictors of cardiac cachexia. Muscle specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 2005; 115:451-458.
47. Sandri M, Sandri C, Gilbert A y cols.: Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117 (3):399-412.
48. Riede UN, Forstermann U, Drexler: Inducible nitric oxide synthase in skeletal muscle of pacientes with chronic heart failure. J Am Coll Cardiol 1998; 32:964-969.
49. Coats AJ, Clark AL, Piepoli M y cols.: Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994; 72 (2 Supl.):36-39.
50. ASPEN Board of Directors and the Clinical Guidelines Task Force: Guidelines for the use of Parenteral and Enteral Nutrition in adults and pediatric patients. J Parent Enter Nutr 2002; 26: (1 Supl.):1-138.
51. Mustafa I, Leverve X: Metabolic and nutritional disorders in cardiac caquexia. Nutrition 2001; 17:756-760.
52. Piepoli MF, Scott AC, Capucci A y cols.: Skeketal muscle training in chronic heart failure. Acta Physiol Scand 2001; 17:295-303.
53. Coats AJ, Adamopoulos S, Meyer TE y cols.: Effects of physical training in chronic heart failure. Lancet 1990; 335:63-66.
54. Coats AJ, Adamopoulos S, Radaelli A y cols.: Controlled trial of physical training in chronic heart failure. Exercise perfomance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85:2119-2131.
55. Hryniewicz K, Androne AS, Hudaihed A y cols.: Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. J Card Fail 2003; 9:464-468.
56. Coirault C, Hagège A, Chemla D y cols.: Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strenght in patients with heart failure. Chest 2001; 119:1755-1760.
57. Vescovo G, Dalla Libera L, Serafini F y cols.: Improved exercise tolerance after Losartan and Enalapril in heart failure. Circulation 1998; 98:1742-1749.
58. Onder G, Penninx B, Balkrishnan R y cols.: Relation between use of angiotensin-converting enzyme inhibitors and muscle strenght and physical function in older women: an observational study. Lancet 2002; 359:926-930.
59. Jeejeebhoy KN, Sole MJ: Nutrition and the heart. Clin Nutr 2001; 20 (supp I): 181-186.